Phase II, 2nd Line Melanoma - RAND Monotherapy
Public ClinicalTrials.gov record NCT00612664. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multi-Dose, Open-Label, Phase II Study of BMS-663513 as a Second-Line Monotherapy in Subjects With Previously Treated Unresectable Stage III or IV Melanoma
Study identification
- NCT ID
- NCT00612664
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 158 participants
Conditions and interventions
Conditions
Interventions
- Anti-CD137 (4-1BB) (BMS-663513) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2008
- Primary completion
- Sep 30, 2009
- Completion
- Sep 30, 2009
- Last update posted
- Oct 11, 2015
2008 – 2009
United States locations
- U.S. sites
- 10
- U.S. states
- 10
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Angeles Clinic & Research Institute | Los Angeles | California | 90025 | — |
| Yale University School Of Medicine | New Haven | Connecticut | 06520 | — |
| Oncology Specialists, S.C. | Park Ridge | Illinois | 60068 | — |
| Indiana University Melvin And Bren Simon Cancer Center | Indianapolis | Indiana | 46202 | — |
| Harry & Jeanette Weinberg Cancer Inst At Franklin Square | Baltimore | Maryland | 21237 | — |
| Dana-Farber Cancer Inst | Boston | Massachusetts | 02115 | — |
| Mem Sloan-Ket Can Ctr | New York | New York | 10021 | — |
| Blumenthal Cancer Center, Carolinas Medical Center | Charlotte | North Carolina | 28204 | — |
| Providence Portland Medical Center | Portland | Oregon | 97213 | — |
| University Of Texas | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00612664, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 11, 2015 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00612664 live on ClinicalTrials.gov.